MedPath

Retrospective cohort study of Sandan Tongluo granule in the treatment of ischemic stroke in convalescent period

Not Applicable
Conditions
Ischemic stroke
Registration Number
ITMCTR2200005576
Lead Sponsor
Affiliated Hospital of Hunan Academy of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Western diagnosis conforms to the diagnostic criteria of ischemic stroke;? TCM diagnosis belongs to apoplexy;? The duration of the disease is between 2 weeks and 6 months;? Good compliance, aged between 18 and 75 years old;(5) with limb dysfunction, and not accompanied by other diseases affecting neurological function and life ability evaluation;? Patients or their family members agree and sign informed consent.

Exclusion Criteria

? The course of treatment is less than 1 month;? The medical records are not complete, and the return visit cannot be obtained.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stroke syndrome diagnosis scale;Degree of neurological impairment;Efficacy end points (fatality rate, recurrence rate);Degree of disability;Cognitive level;Ability to perform daily living activities;
Secondary Outcome Measures
NameTimeMethod
The basic information;
© Copyright 2025. All Rights Reserved by MedPath